Back to results
US 10,898,472 B2Granted
Detecting and treating growth hormone deficiency
AssigneeLumos Pharma, Inc.
InventorMichael Oliver Thorner
Life of this patent
Estimating the term…
Abstract
Described herein is a new oral method for using MK-0677 for detecting growth hormone (GH) deficiency (GHD). Also described is a method of treating growth hormone (GH) deficiency (GHD) in children with a functional hypothalamic-pituitary GH axis.
Claims2
A theranostic test for treating a child having a growth hormone deficiency, comprising:
- (i.) testing the child for a peak serum GH ≥5 μg/L in response to a single oral dose of MK-0677;
- and
- (ii.) testing the child for a baseline serum IGF-I of >30 ng/mL.
Dependencies are inferred from the claim text.